These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

524 related items for PubMed ID: 15784302

  • 1. Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson's disease.
    Fedorow H, Tribl F, Halliday G, Gerlach M, Riederer P, Double KL.
    Prog Neurobiol; 2005 Feb; 75(2):109-24. PubMed ID: 15784302
    [Abstract] [Full Text] [Related]

  • 2. The enigma of neuromelanin in Parkinson's disease substantia nigra.
    Youdim MB, Ben-Shachar D, Riederer P.
    J Neural Transm Suppl; 1994 Feb; 43():113-22. PubMed ID: 7884393
    [Abstract] [Full Text] [Related]

  • 3. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM, Ophof A, Broe M, Jensen PH, Kettle E, Fedorow H, Cartwright MI, Griffiths FM, Shepherd CE, Double KL.
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [Abstract] [Full Text] [Related]

  • 4. Modifications of the iron-neuromelanin system in Parkinson's disease.
    Fasano M, Bergamasco B, Lopiano L.
    J Neurochem; 2006 Feb; 96(4):909-16. PubMed ID: 16417570
    [Abstract] [Full Text] [Related]

  • 5. Neuromelanin and Parkinson's disease.
    Marsden CD.
    J Neural Transm Suppl; 1983 Feb; 19():121-41. PubMed ID: 6321645
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson's disease.
    Zecca L, Casella L, Albertini A, Bellei C, Zucca FA, Engelen M, Zadlo A, Szewczyk G, Zareba M, Sarna T.
    J Neurochem; 2008 Aug; 106(4):1866-75. PubMed ID: 18624918
    [Abstract] [Full Text] [Related]

  • 12. On the origin and significance of neuromelanin.
    Graham DG.
    Arch Pathol Lab Med; 1979 Jul; 103(7):359-62. PubMed ID: 582279
    [Abstract] [Full Text] [Related]

  • 13. A critical review of the function of neuromelanin and an attempt to provide a unified theory.
    Nicolaus BJ.
    Med Hypotheses; 2005 Jul; 65(4):791-6. PubMed ID: 15949901
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.
    Zecca L, Wilms H, Geick S, Claasen JH, Brandenburg LO, Holzknecht C, Panizza ML, Zucca FA, Deuschl G, Sievers J, Lucius R.
    Acta Neuropathol; 2008 Jul; 116(1):47-55. PubMed ID: 18343932
    [Abstract] [Full Text] [Related]

  • 16. Using Sepia melanin as a PD model to describe the binding characteristics of neuromelanin - A critical review.
    Schroeder RL, Double KL, Gerber JP.
    J Chem Neuroanat; 2015 Jul; 64-65():20-32. PubMed ID: 25681296
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Immobilization stress causes increases in tetrahydrobiopterin, dopamine, and neuromelanin and oxidative damage in the nigrostriatal system.
    Kim ST, Choi JH, Chang JW, Kim SW, Hwang O.
    J Neurochem; 2005 Oct; 95(1):89-98. PubMed ID: 16181415
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.